How Do You Choose a Second-Line Treatment Option for Depression?

被引:1
|
作者
Weisler, Richard H. [1 ,2 ]
机构
[1] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[2] Duke Univ, Dept Psychiat, Durham, NC 27706 USA
关键词
ANTIDEPRESSANT THERAPY; POSTSTROKE DEPRESSION; MYOCARDIAL-INFARCTION; SEXUAL DYSFUNCTION; CARDIAC MORTALITY; SSRIS; RISK; AUGMENTATION; MEDICATION; BUPROPION;
D O I
10.4088/JCP.9104su1c.04
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
A majority of patients with major depression do not remit or adequately respond to initial antidepressant therapy. When response is insufficient, a diagnosis of depression and any comorbidities should be confirmed, treatment adherence should be established, and antidepressant dosages should be optimized as tolerated. If response is still insufficient, then implementing second-line treatment strategies is warranted. Second-line strategies of switching to or combining/augmenting the initial agent with one of a variety of antidepressant medications and/or psychotherapies improves remission rates, although no single approach or agent has demonstrated clear superiority over any other. Second-line treatment selections should be driven by safety considerations, patients' symptom profiles, and patient preference. Comorbid medical conditions, especially cardiac and cerebrovascular complications, and potential drug-drug interactions should be considered when making treatment decisions. (J Clin Psychiatry 2010;71[suppl 1]:21-26)
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条